Thyroid Carcinoma, Anaplastic

4 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Carcinoma, Neoplasms

Treatments and conditions

Thyroid Carcinoma, Anaplastic
Treatment and conditionWhere it standsTrials
Conventional Surgery + Intensity-Modulated Radiation Therapy + Quality-of-Life Assessment + Trametinib + PEMBROLIZUMAB + DABRAFENIB for thyroid carcinoma, anaplasticPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
dabrafenib/trametinib for thyroid carcinoma, anaplasticPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Selective coverage radiotherapy for thyroid carcinoma, anaplasticPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Trametinib + DABRAFENIB for thyroid carcinoma, anaplasticPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.